Privi Speciality Chemicals Ltd – Weekly Breakout Setup

Privi has shown a clean breakout from a long consolidation zone, backed by steady volume expansion. After months of range-bound action, the stock finally broke above ₹2,600 and is now sustaining well above its breakout zone — indicating the start of a new upward leg.
Price action shows strong bullish candles supported by the 10- and 20-week EMAs, signaling trend confirmation.
🎯 Key Levels:
CMP: ₹2,903 (+2.55%)
Breakout Zone: ₹2,500 – ₹2,600
Target Zone: ₹3,150 – ₹3,250
Stop-Loss: ₹2,700 (weekly close basis)
📊 Technical View:
Weekly breakout from multi-month consolidation box.
Volume confirmation supports sustained momentum.
Price trading above both EMAs, confirming bullish trend continuation.
Minor resistance near ₹2,950; sustained move above can accelerate momentum.
🧠 View:
Privi Speciality Chemicals has completed a strong breakout after a long accumulation phase. Sustaining above ₹2,900 can push the stock towards ₹3,200 levels in the coming weeks.
Price action shows strong bullish candles supported by the 10- and 20-week EMAs, signaling trend confirmation.
🎯 Key Levels:
CMP: ₹2,903 (+2.55%)
Breakout Zone: ₹2,500 – ₹2,600
Target Zone: ₹3,150 – ₹3,250
Stop-Loss: ₹2,700 (weekly close basis)
📊 Technical View:
Weekly breakout from multi-month consolidation box.
Volume confirmation supports sustained momentum.
Price trading above both EMAs, confirming bullish trend continuation.
Minor resistance near ₹2,950; sustained move above can accelerate momentum.
🧠 View:
Privi Speciality Chemicals has completed a strong breakout after a long accumulation phase. Sustaining above ₹2,900 can push the stock towards ₹3,200 levels in the coming weeks.
Declinazione di responsabilità
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Declinazione di responsabilità
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.